

Pro-choice advocates told Newsweek that a decision in a New Orleans appeals court that blocked the distribution of mifepristone through the mail is "one step closer to a national abortion ban."Mini Timmaraju, president and CEO of Reproductive Freedom for All, in an email comment wrote: "It is now much more difficult for people to access abortion care. Anti-abortion politicians know their policies are unpopular, so they are using every lever of government they can."Louisiana built this case on debunked, junk science," Timmaraju wrote. "The safety of mifepristone has never actually been in question. As this case moves towards the U.S. Supreme Court, we will fight until every person has access to the care they need.”Louisiana Appeals Court Blocks Mifepristone by Mail: What to KnowA three-judge panel in New Orleans on Friday blocked a federal rule allowing the distribution of the abortion drug mifepristone through the mail, according to Reuters. "The agency's progressive relaxation of mifepristone's guardrails likely lacked a basis in data and scientific literature," Circuit Judge Stuart Kyle Duncan, a Trump appointee, wrote for the court, agreeing that the FDA has failed to justify eliminating the in-person requirement for dispensing it. The state of Louisiana brought a challenge against
Lean: n/a · Source quality n/a · Factual vs opinion n/a.
© 2026 Vistoa. All rights reserved.
Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.